Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out‐of‐hospital seizure clusters: Results from a phase 3, open‐label, repeat‐dose safety study

OBJECTIVE: An exploratory analysis from a long‐term, phase 3, open‐label, repeat‐dose safety study of diazepam nasal spray for acute treatment of seizure clusters assessed the use of a second dose up to 24 hours after the initial dose and effectiveness in potentially reducing the number of seizures....

Descripción completa

Detalles Bibliográficos
Autores principales: Sperling, Michael R., Wheless, James W., Hogan, R. Edward, Dlugos, Dennis, Cascino, Gregory D., Liow, Kore, Rabinowicz, Adrian L., Carrazana, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305147/
https://www.ncbi.nlm.nih.gov/pubmed/35112342
http://dx.doi.org/10.1111/epi.17177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305147/
https://www.ncbi.nlm.nih.gov/pubmed/35112342
http://dx.doi.org/10.1111/epi.17177

Ejemplares similares